BCAX
Bicara Therapeutics Inc.
$10.75
+$0.31(+2.97%)
41
Overall
--
Value
41
Tech
--
Quality
Market Cap
$569.64M
Volume
261.03K
52W Range
$7.80 - $28.09
Target Price
$33.00
EPS Estimates Overview
| Current Quarter | $-0.55 | Next Quarter | $-0.6 |
| Current Year | $-2.32 | Next Year | $-2.71 |
| QoQ Growth | -9.1% | YoY Growth | -16.8% |
| 3Y EPS CAGR | N/A | Target Price | $33.00 |
| Consensus | Buy | Upside | +207.0% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCAX | $10.75 | +3.0% | 261.03K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bicara Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW